Company Information
Industry 批发和零售业
Company Introduction 塞力医疗(股票代码:603716)成立于2004年2月,总部位于湖北省武汉市,自有2.7万平方米产业园。公司于2016年10月成功登陆资本市场,是中部地区首家沪市主板上市的医疗集约化运营服务提供商。 公司自成立以来,一直深耕于医疗集约化运营管理服务领域,积累了丰富的行业经验;公司已与国内外知名IVD供应商建立了长期良好的合作关系,覆盖了医疗机构所需的全采购品类,能满足医疗机构对体外诊断产品的一站式需求。 公司在供应链信息化、区块链、物联网等信息技术领域深度布局,与专业从事大数据及信息管理系统平台开发的公司保持了紧密的合作关系,为集约化运营服务平台的建设提供了强有力的技术支持。
Main Business 集约化销售业务、单纯销售以及自主体外诊断产品的研发、生产和销售。
Legal Representative 温伟
Top Executives
董事长:温伟
董事:王政,温一丞,范莉,温小明
独立董事:张震,张兆国,施先旺
Top 5 Shareholder
Shareholder name Nature Holding Date
赛海(上海)健康科技有限公司流通A股10.75%30/09/2024
上海盎泽私募基金管理有限公司-盎泽太盈六号私募证券投资基金流通A股6.95%30/09/2024
温伟流通A股4.79%30/09/2024
MERRILL LYNCH INTERNATIONAL流通A股0.98%30/09/2024
湖北省长江精选棘轮一号生态投资合伙企业(有限合伙)流通A股0.88%30/09/2024
Company Secretary 范莉
Solicitors 国浩律师(上海)事务所
Auditors 中审众环会计师事务所(特殊普通合伙)
Tel No 027-83386378
Fax No 027-83084202
Website www.thalys.net.cn
Email ir@thalys.net.cn
Company Address
Register: 湖北省武汉市东西湖区金山大道1310号
Office: 湖北省武汉市东西湖区金山大道1310号
Listing Date 31/10/2016
Shares Capital
Shares Capital: 190,986,254
Total A Share: 190,986,254
Listed A Share: 190,986,254
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.820
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 5.526
Market Capitalization(RMB) 1.568B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.